Baidu
map

消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2018 JSMO临床指南：结直肠癌治疗的分子检测（第3版）

2018-06-03 日本肿瘤内科学会 Cancer Sci. 2018 Jun;109(6):2074-2079.

结直肠癌分子检测

日本肿瘤内科学会(JSMO)前期共发布两版分子检测指南，分别为2008年结直肠癌KRAS基因突变检测指南和2014年结直肠癌RAS (KRAS/NRAS) 检测指南。本文为第3版结直肠癌治疗的分子检测指南，主要内容包括结直肠癌治疗分子检测的基本要求和目前的检测技术以及未来前景。

中文标题：

2018 JSMO临床指南：结直肠癌治疗的分子检测（第3版）

英文标题：

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.

发布机构：

日本肿瘤内科学会

发布日期：

2018-06-03

简要介绍：

日本肿瘤内科学会(JSMO)前期共发布两版分子检测指南，分别为2008年结直肠癌KRAS基因突变检测指南和2014年结直肠癌RAS (KRAS/NRAS) 检测指南。本文为第3版结直肠癌治疗的分子检测指南，主要内容包括结直肠癌治疗分子检测的基本要求和目前的检测技术以及未来前景。 

拓展指南：与结直肠癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 JSMO临床指南：结直肠癌治疗的分子检测（第3版）)] GetToolGuiderByIdResponse(projectId=1, id=fc2d81c00160218c, title=2018 JSMO临床指南：结直肠癌治疗的分子检测（第3版）, enTitle=Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition., guiderFrom=Cancer Sci. 2018 Jun;109(6):2074-2079., authorId=null, author=, summary=日本肿瘤内科学会(JSMO)前期共发布两版分子检测指南，分别为2008年结直肠癌KRAS基因突变检测指南和2014年结直肠癌RAS (KRAS/NRAS) 检测指南。本文为第3版结直肠癌治疗的分子检测指南，主要内容包括结直肠癌治疗分子检测的基本要求和目前的检测技术以及未来前景。 , cover=, journalId=null, articlesId=null, associationId=1667, associationName=日本肿瘤内科学会, associationIntro=, copyright=0, guiderPublishedTime=Sun Jun 03 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>日本肿瘤内科学会(JSMO)前期共发布两版分子检测指南，分别为2008年结直肠癌KRAS基因突变检测指南和2014年结直肠癌RAS (KRAS/NRAS) 检测指南。本文为第3版结直肠癌治疗的分子检测指南，主要内容包括结直肠癌治疗分子检测的基本要求和目前的检测技术以及未来前景。 </div> <div><br> </div>拓展指南：<strong>与<font color="red">结直肠癌</font>相关指南：</strong><br><ul><li><a title="2018 ACS指南：平均风险成年人群结直肠癌筛查" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=c45a31c0015991f5">2018 ACS指南：平均风险成年人群结直肠癌筛查</a></li> <li><a title="中国医促会结直肠癌肝转移分会结直肠癌肝转移MDT诊治共识（讨论版）" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=61f141c0015906c8">中国医促会结直肠癌肝转移分会结直肠癌肝转移MDT诊治共识（讨论版）</a></li> <li><a title="结直肠癌分子生物标志物检测专家共识" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=34f741c00158ae8a">结直肠癌分子生物标志物检测专家共识</a></li> <li><a title="NCCN临床实践指南：结直肠癌筛查（2018.V1）" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=f9fab1c0015e780e">NCCN临床实践指南：结直肠癌筛查（2018.V1）</a></li> <li><a title="遗传性结直肠癌临床诊治和家系管理中国专家共识" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=15c941c0015a8373">遗传性结直肠癌临床诊治和家系管理中国专家共识</a></li> 更多信息请点击：<a target="_blank" href="//m.capotfarm.com/guideline/list.do?q=%E7%BB%93%E7%9B%B4%E8%82%A0%E7%99%8C">有关结直肠癌更多指南</a></ul>, tagList=[TagDto(tagId=539, tagName=结直肠癌), TagDto(tagId=19983, tagName=分子检测)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6104, appHits=364, showAppHits=0, pcHits=4410, showPcHits=1973, likes=153, shares=6, comments=4, approvalStatus=1, publishedTime=Sun Jun 10 22:37:53 CST 2018, publishedTimeString=2018-06-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 10 22:37:53 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:39:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 JSMO临床指南：结直肠癌治疗的分子检测（第3版）)])
2018 JSMO临床指南：结直肠癌治疗的分子检测（第3版）
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=323282, encodeId=253f3232822f, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 11 09:03:57 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323259, encodeId=a020323259cb, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jun 11 08:13:46 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323229, encodeId=01ba323229ac, content=了解一下谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Mon Jun 11 07:10:32 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323142, encodeId=d9023231422a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sun Jun 10 23:08:19 CST 2018, time=2018-06-10, status=1, ipAttribution=)]
    2018-06-11 明月清辉

    谢谢分享.学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=323282, encodeId=253f3232822f, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 11 09:03:57 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323259, encodeId=a020323259cb, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jun 11 08:13:46 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323229, encodeId=01ba323229ac, content=了解一下谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Mon Jun 11 07:10:32 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323142, encodeId=d9023231422a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sun Jun 10 23:08:19 CST 2018, time=2018-06-10, status=1, ipAttribution=)]
    2018-06-11 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=323282, encodeId=253f3232822f, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 11 09:03:57 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323259, encodeId=a020323259cb, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jun 11 08:13:46 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323229, encodeId=01ba323229ac, content=了解一下谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Mon Jun 11 07:10:32 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323142, encodeId=d9023231422a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sun Jun 10 23:08:19 CST 2018, time=2018-06-10, status=1, ipAttribution=)]
    2018-06-11 kafei

    了解一下谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=323282, encodeId=253f3232822f, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 11 09:03:57 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323259, encodeId=a020323259cb, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jun 11 08:13:46 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323229, encodeId=01ba323229ac, content=了解一下谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Mon Jun 11 07:10:32 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323142, encodeId=d9023231422a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sun Jun 10 23:08:19 CST 2018, time=2018-06-10, status=1, ipAttribution=)]
    2018-06-10 紫迎馨

    学习

    0

相关指南

结直肠癌分子生物标志物检测专家共识

暂未更新 · 2018-04-10

中国结直肠癌诊疗规范（2017版）主要更新概要

暂未更新 · 2018-01-10

中国结直肠癌诊疗规范（2017版）

中华人民共和国国家卫生和计划生育委员会(NHFPC,National Health and Family Planning Commission of China) · 2017-12-15

结直肠癌腹膜转移诊治中国专家意见（2017）

中国医师协会结直肠肿瘤专委会 腹膜肿瘤专业委员会 · 2017-10-30

2017 NICE诊断指南：结直肠癌患者林奇综合征分子检测策略（DG.27）

暂未更新 · 2017-02-22

2017 ASER/POQI联合共识声明：优化镇痛加速结直肠癌手术康复（二）

美国促进恢复学会(ASER,American Society for Enhanced Recovery) · 2017-04-13

Baidu
map
Baidu
map
Baidu
map